ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Mesirow Institutional Investment Management Inc.

Mesirow Institutional Investment Management Inc. decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 4.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 116,771 shares of the medical instruments supplier’s stock after selling 5,306 shares during the quarter. ICU Medical makes up about 1.4% of Mesirow Institutional Investment Management Inc.’s holdings, making the stock its 13th biggest holding. Mesirow Institutional Investment Management Inc.’s holdings in ICU Medical were worth $18,119,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Natixis acquired a new stake in ICU Medical in the 4th quarter valued at approximately $869,000. Dimensional Fund Advisors LP grew its stake in shares of ICU Medical by 18.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock valued at $83,788,000 after buying an additional 82,982 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in ICU Medical by 0.7% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 28,476 shares of the medical instruments supplier’s stock worth $4,412,000 after acquiring an additional 188 shares in the last quarter. Gabelli Funds LLC lifted its stake in ICU Medical by 1.4% during the 4th quarter. Gabelli Funds LLC now owns 70,500 shares of the medical instruments supplier’s stock worth $10,939,000 after acquiring an additional 950 shares in the last quarter. Finally, Mariner LLC boosted its holdings in ICU Medical by 24.4% during the 4th quarter. Mariner LLC now owns 5,009 shares of the medical instruments supplier’s stock valued at $777,000 after acquiring an additional 984 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Performance

NASDAQ:ICUI opened at $138.67 on Friday. The firm has a market capitalization of $3.40 billion, a PE ratio of -30.34 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The business’s fifty day moving average price is $146.34 and its 200 day moving average price is $159.60. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on ICUI shares. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.